Now, the university has received a US$100,000 boost through one of more than 50 Grand Challenges Explorations (GCE) Round 10 grants by the Bill & Melinda Gates Foundation.
GCE is a US$100 million initiative funded by the Foundation which backs individuals worldwide to find ways to solve persistent global health and development challenges.
"We've got a bit of technology here that has some real legs, and we're thrilled to be recognised by a group that has the wherewithal and capacity to deliver benefits to those who need it most around the world," Dr Sowerby said.
He will work with colleagues at the university's Centre for International Health, the company Menixis, and others to validate how well the new approach performs in humans compared to the standard McMaster test.
Successful projects have the opportunity to receive a GCE follow-on grant of up to US$1m, and Dr Sowerby says: "We're anticipating success."
"Parasitology is an enormous, neglected problem especially in the developing world, with around 1.5 million people per annum infected with intestinal parasites that can be diagnosed by this sort of technology."